Cancer Clinical Investigators Should Converge with Pharmacometricians.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 31248883.
- Also identified by DOI 10.1158/1078-0432.CCR-19-1067 and PMC identifier 8121188.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The applied quantitative science pharmacometrics has significantly enhanced cancer therapeutics development. Pharmacometrics is now improving our understanding of complex diagnostics. Through the concept of convergence and methods of quantitative and systems pharmacology, pharmacometrics is poised to interconnect mathematical models of disease and therapy to advance cancer care.<i>See related article by Colomban et al., p. 5342</i>.
Medical subject headings
- Carcinoma, Ovarian Epithelial
- Ovarian Neoplasms